Solvonis Therapeutics (LSE:SVNS) Cash per Share : £0.00 (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Solvonis Therapeutics Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Solvonis Therapeutics's Cash per Share for the quarter that ended in Sep. 2024 was £0.00.

Solvonis Therapeutics Cash per Share Historical Data

The historical data trend for Solvonis Therapeutics's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solvonis Therapeutics Cash per Share Chart

Solvonis Therapeutics Annual Data

Trend

May18

May19

May20

May21

Dec22

Dec23

Cash per Share

Get a 7-Day Free Trial

0.02

Solvonis Therapeutics Quarterly Data
	May18	May19	May20	May21	Dec21	Jun22	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Cash per Share	Get a 7-Day Free Trial							0.01	-	-	-	-

Solvonis Therapeutics Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Solvonis Therapeutics's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0.155	/	104.10
	=	0.00

Solvonis Therapeutics's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0.94	/	2,295.93
	=	0.00

Solvonis Therapeutics (LSE:SVNS) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Solvonis Therapeutics Cash per Share Related Terms

Thank you for viewing the detailed overview of Solvonis Therapeutics's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Solvonis Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Solvonis Therapeutics PLC (LSE:SVNS) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

J4I:Germany

Address

Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF

Website

https://www.solvonis.com

Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.

Solvonis Therapeutics Headlines

No Headlines